Organic Letters · 2020 · 26 citations · 39 references
PharmacyChemistryMedicinal ChemistryCatalysisDrug DiscoverySynthetic Medicinal ChemistryDiversity-oriented SynthesisMacrocycle SynthesisAsymmetric CatalysisAsymmetric Heterocycle SynthesisAsymmetric SynthesisChiral Product SynthesisEnantioselective SynthesisPhosphoramidite Chemistry
A new ruthenium-based catalytic system for branched-selective asymmetric allylic alkylation is disclosed and applied to the synthesis of chiral isatin derivatives. The catalyst, which is generated in situ from commercially available CpRu(MeCN)3PF6 and a BINOL-derived phosphoramidite, is both highly active (TON up to 180) and insensitive to air and moisture. Additionally, the N-alkylated isatins accessible using this methodology are versatile building blocks that are readily transformed into chiral analogs of achiral drug molecules.
39
CHEM21 selection guide of classical- and less classical-solvents
Denis Prat, A.S. Wells, John Hayler et al. · Green Chemistry · 2015 · 2.1K citations · Full text
Iridium-catalysed asymmetricallylic substitutions
Günter Helmchen, Axel Dahnz, Pierre Dübon et al. · Chemical Communications · 2006 · 495 citations
Li Sun, Ngoc Quang Tran, Flora Tang et al. · Journal of Medicinal Chemistry · 1998 · 488 citations · Full text